comparemela.com
  1. Home
  2. Live Updates
  3. Capital Markets Nominated Adviser - Breaking News

Latest Breaking News On - Capital markets nominated adviser - Page 1 : comparemela.com

4D pharma plc (4D pharma) Receives Notice of Delisting From Nasdaq

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that

United statesJulie seidelNeil hunter michelle boxallDominic wilsonPhilip davies james fischerBryan garnier coHearing panelImage box communicationsMerck co incExchange commissionUnited states securities exchangeNasdaq stock marketListing rulesNasdaq staffNasdaq stockNasdaq listing rule

4D pharma: Update on Suspension of Trading

4D pharma plc (AIM: DDDD, Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, provides an update

United statesUnited kingdomCity ofJulie seidelNeil hunter michelle boxallDavid pikeJames clarkD pharma leDominic wilsonPhilip davies james fischerBryan garnier coD pharma researchD pharma corkImage box communicationsMerck co incOxford finance

4D pharma to Present at the H C Wainwright Global Investment Conference

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced

United statesJulie seidelNeil hunter michelle boxallDuncan peytonDominic wilsonPhilip davies james fischerMerck co incBryan garnier coImage box communicationsChief executive officerGlobal investmentCapital markets nominated adviserJoint brokerDavies james fischerCorporate financeCorporate broking

4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces

United statesSan franciscoJulie seidelBiotherapeutic mrxNeil hunter michelle boxallAlex stevensonDominic wilsonPhilip davies james fischerBryan garnier coImage box communicationsExchange commissionMerck co incUnited states securities exchangeInternational conferenceAmerican thoracic societyThoracic society

4D pharma plc: 4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022

4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today reported financial

United statesUnited kingdomJulie seidelNeil hunter michelle boxallDuncan peytonDominic wilsonLynne dardanellJohn beckPhilip davies james fischerBryan garnier coImage box communicationsDevelopment milestonesMerck co incDevelopment expensesMerck kgaUnited states securities exchange

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.